GIP is similar to GLP-1
Clinical trials primarily documented gastrointestinal side effects such as nausea, vomiting, and diarrhoea
No more random snack cravings throughout the day Smaller portions feel just as satisfying as large ones used to The feeling of being full lasts longer after meals Getting started with Willow Three simple steps to weight loss care 1 Free assessment Start with some quick questions about your health history and goals to see if youre eligible for same-day approval
Learn More About Ozempic Lawsuits From Our Legal Team Individuals who have suffered a serious injury after taking Ozempic, such as gastroparesis, intestinal blockage, vision loss, or blood clots, may be entitled to significant compensation
Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, glucagon) that remains unlicensed in the UK, with no MHRA approval, no NHS availability, and no BNF listing as of 20242025